Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture.
暂无分享,去创建一个
Ick Chan Kwon | I. Kwon | M. Lee | J. E. Lee | Sang Cheol Seong | Myung Chul Lee | Jong Eun Lee | S. Seong | Hee Joong Kim | Hyun Jeong Ahn | Sang-Hoon Lee | Hyunchul Cho | Seoung Eun Kim | H. Ahn | Hee-Joong Kim | H. Cho | Sang-Hoon Lee | S. Kim
[1] Ick Chan Kwon,et al. Preparation of sodium alginate microspheres containing hydrophilic β-lactam antibiotics , 1996 .
[2] Freddie H. Fu,et al. GAG-augmented polysaccharide hydrogel: A novel biocompatible and biodegradable material to support chondrogenesisNo benefit of any kind will be received either directly or indirectly by the authors. , 2000 .
[3] T. Chandy,et al. Chitosan--as a biomaterial. , 1990, Biomaterials, artificial cells, and artificial organs.
[4] J. Suh,et al. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. , 2000, Biomaterials.
[5] I. Kwon,et al. Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[6] O. Damour,et al. Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. , 1998, Biomaterials.
[7] Tom Minas,et al. Current concepts in the treatment of articular cartilage defects. , 1997, Orthopedics.
[8] S. Madihally,et al. Porous chitosan scaffolds for tissue engineering. , 1999, Biomaterials.
[9] Joong,et al. The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes. , 2003, Osteoarthritis and cartilage.
[10] A J Nixon,et al. Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1. , 1997, American journal of veterinary research.
[11] H J Mankin,et al. Articular cartilage: tissue design and chondrocyte-matrix interactions. , 1998, Instructional course lectures.
[12] Y Ikada,et al. Fabrication of porous gelatin scaffolds for tissue engineering. , 1999, Biomaterials.
[13] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.
[14] R. Muzzarelli,et al. Osteoconductive properties of methylpyrrolidinone chitosan in an animal model. , 1993, Biomaterials.
[15] D. Hungerford,et al. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. , 2000, Journal of biomedical materials research.
[16] A. Mikos,et al. Review: tissue engineering for regeneration of articular cartilage. , 2000, Biomaterials.
[17] Q. Myrvik,et al. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice , 1997, Infection and immunity.
[18] K. Zhu,et al. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. , 2001, Journal of microencapsulation.
[19] J. Mao,et al. Structure and properties of bilayer chitosan-gelatin scaffolds. , 2003, Biomaterials.
[20] J. Verhaar,et al. Growth factors in cartilage tissue engineering. , 2002, Biorheology.
[21] Robert Langer,et al. Controlled‐release of IGF‐I and TGF‐β1 in a photopolymerizing hydrogel for cartilage tissue engineering , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[22] L. Illum,et al. Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.
[23] A. Mikos,et al. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[24] Mark Saltzman W,et al. Materials for protein delivery in tissue engineering. , 1998, Advanced drug delivery reviews.
[25] A. Mikos,et al. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .
[26] G. Vunjak‐Novakovic,et al. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. , 2002, Biochemical and biophysical research communications.
[27] M. Nimni. Polypeptide growth factors: targeted delivery systems. , 1997, Biomaterials.
[28] E. Fu,et al. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. , 2003, Biochemical and biophysical research communications.
[29] I. Kwon,et al. Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[30] M. Murakami,et al. Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. , 2001, Biomaterials.
[31] M J Yaszemski,et al. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. , 2000, Journal of biomedical materials research.
[32] C. Malemud,et al. The role of growth factors in cartilage metabolism. , 1993, Rheumatic diseases clinics of North America.
[33] E. Edelman,et al. Cellular Response to Transforming Growth Factor-β1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions* , 1996, The Journal of Biological Chemistry.
[34] Lonnie D Shea,et al. Drug-releasing scaffolds fabricated from drug-loaded microspheres. , 2002, Journal of biomedical materials research.
[35] K. Yao,et al. Biomimetic surface modification of poly(L-lactic acid) with chitosan and its effects on articular chondrocytes in vitro. , 2003, Biomaterials.
[36] K. Zhu,et al. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. , 2002, International journal of pharmaceutics.